Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0A1DE
|
|||
Former ID |
DNC005872
|
|||
Drug Name |
MDL-28163
|
|||
Synonyms |
MDL-28163; CHEMBL95051; SCHEMBL9196398; DIPBPGRFGZKMEF-UHFFFAOYSA-N; BDBM50175511; 1-(4-Fluorobenzyl)-2-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinylcarbonyl]-1H-benzimidazole; [1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-yl][1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]methanone
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C29H30FN3O2
|
|||
Canonical SMILES |
COC1=CC=C(C=C1)CCN2CCC(CC2)C(=O)C3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F
|
|||
InChI |
1S/C29H30FN3O2/c1-35-25-12-8-21(9-13-25)14-17-32-18-15-23(16-19-32)28(34)29-31-26-4-2-3-5-27(26)33(29)20-22-6-10-24(30)11-7-22/h2-13,23H,14-20H2,1H3
|
|||
InChIKey |
DIPBPGRFGZKMEF-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 124461-07-0
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Histamine H1 receptor (H1R) | Target Info | Inhibitor | [1] |
Substance-P receptor (TACR1) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Calcium signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Measles | ||||
Inflammatory mediator regulation of TRP channels | ||||
Panther Pathway | CCKR signaling map ST | |||
Histamine H1 receptor mediated signaling pathway | ||||
Reactome | G alpha (q) signalling events | |||
Histamine receptors | ||||
WikiPathways | SIDS Susceptibility Pathways | |||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
Spinal Cord Injury | ||||
Peptide GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
Monoamine GPCRs | ||||
GPCRs, Class A Rhodopsin-like | ||||
IL-4 Signaling Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem. 2005 Oct 20;48(21):6523-43. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.